During these two years of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, it has become increasingly clear that about 50% of patients who died from Coronavirus disease 2019 (COVID-19) had metabolic disorders, mainly obesity, type 2 diabetes, hypertension, or non-alcoholic fatty liver disease. Notably, experimental and observational studies have reported a complex and bidirectional relationship between COVID-19 and metabolic disorders. Indeed, on one side, patients with diabetes or other metabolic disorders have a higher risk of severe illness from COVID-19 and greater in-hospital mortality than those without metabolic disorders and, on the other side, COVID-19 may contribute to worse pre-existing metabolic disorders or even lead to new-onset diabetes or other metabolic disorders.
This Special issue of Metabolism and Target Organ Damage will focus on new experimental and epidemiological data in the area of the bidirectional links between COVID-19 and metabolic disorders. In particular, it will cover a selection of research and review articles on the following potential issues:Predisposition to severe illness from COVID-19 in patients with metabolic disorders;
Experimental papers, epidemiological papers, up-to-date review articles, systematic reviews and meta-analyses, and commentaries are all welcome.I hope you enjoy reading this edition of the journal.
Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://mtodjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=mtod&SpecialIssueId=mtod211228
Submission Deadline: 15 Oct 2022
Contacts: Doreen Deng, Managing Editor, email@example.com
Zoe Zhang, Assistant Editor, firstname.lastname@example.org